Author:
Mishima Kenichi,Kitoh Hiroshi,Haga Nobuhiko,Nakashima Yasuharu,Kamizono Junji,Katagiri Takenobu,Susami Takafumi,Matsushita Masaki,Ishiguro Naoki
Publisher
International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)
Reference18 articles.
1. 1. Shore EM, Xu M, Feldman GJ, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006; 38:525-527.
2. 2. Kitterman JA, Kantanie S, Rocke DM, Kaplan FS. Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. Pediatrics. 2005; 116:e654-e661.
3. 3. Kitoh H, Achiwa M, Kaneko H, Mishima K, Matsushita M, Kadono I, Horowitz JD, Sallustio BC, Ohno K, Ishiguro N. Perhexiline maleate in the treatment of fibrodysplasia ossificans progressiva: An open-labeled clinical trial. Orphanet J Rare Dis. 2013; 8:163.
4. 4. Pignolo RJ, Shore EM, Kaplan FS. Fibrodysplasia ossificans progressiva: Diagnosis, management, and therapeutic horizons. Pediatr Endocrinol Rev. 2013; 10 (Suppl 2):437-448.
5. 5. Nakashima Y, Haga N, Kitoh H, Kamizono J, Tozawa K, Katagiri T, Susami T, Fukushi J, Iwamoto Y. Deformity of the great toe in fibrodysplasia ossificans progressiva. J Orthop Sci. 2010; 15:804-809.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献